Skip to main content
. 2021 Apr 15;138(1):11–22. doi: 10.1182/blood.2020009098

Table 4.

Response to KTE-X19

Response category Dose level Total (N = 45)
2 × 106 (n = 6) 1 × 106 (n = 23) 0.5 × 106 (n = 16)
CR 4 (67) 19 (83) 8 (50) 31 (69)
 CR 3 (50) 15 (65) 6 (38) 24 (53)
 CRi 1 (17) 4 (17) 2 (13) 7 (16)
BFBM 0 1 (4) 1 (6) 2 (4)
Partial remission 0 1 (4)* 0 1 (2)
No response 1 (17) 2 (9) 6 (38) 9 (20)
Unknown or not evaluable 1 (17) 0 1 (6) 2 (4)

Data are presented as n (%).

*

Patient had extramedullary disease at response assessment. Of the 3 other patients with extramedullary disease, 2 achieved a CR, and 1 had stable disease (no response); all had extramedullary disease present at response assessment.

Patient died on day 6 as a result of multiorgan failure secondary to CRS.

Patient died on day 7 as a result of cerebrovascular accident (stroke) in the context of CRS and neurologic events.